Hydromorphone Extended-Release Tablets and Mogamulizumab-kpkc
Determining the interaction of Hydromorphone Extended-Release Tablets and Mogamulizumab-kpkc and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydromorphone
Brand name: Dilaudid, Exalgo, Hydrostat IR, Dilaudid-HP
Synonyms: Hydromorphone, HYDROmorphone
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydromorphone Extended-Release Tablets-Mogamulizumab-kpkc Intravenous
- Hydromorphone Extended-Release Tablets-Molindone
- Hydromorphone Extended-Release Tablets-Mometasone (Oral Inhalation)
- Hydromorphone Extended-Release Tablets-Mometasone and Formoterol
- Hydromorphone Extended-Release Tablets-Mometasone and formoterol Inhalation
- Hydromorphone Extended-Release Tablets-Mometasone Cream
- Mogamulizumab-kpkc-Hydromorphone Hydrochloride
- Mogamulizumab-kpkc-Hydromorphone injection
- Mogamulizumab-kpkc-Hydromorphone Liquid
- Mogamulizumab-kpkc-Hydromorphone rectal
- Mogamulizumab-kpkc-Hydromorphone Suppository
- Mogamulizumab-kpkc-Hydromorphone Tablets